- Research article
- Open Access
Escherichia coli-derived outer membrane vesicles are genotoxic to human enterocyte-like cells
Infectious Agents and Cancer volume 9, Article number: 2 (2014)
Colorectal cancers are the third most common type in the world. The causes of the disease are poorly understood, but since the discovery of Helicobacter pylori as a causative agent of gastric cancer, attention has turned to bacteria as a possible trigger for colorectal cancer. Recently H. pylori outer membrane vesicles (OMVs) were revealed as potentially genotoxic which can be important first step in carcinogenesis. We therefore investigated whether OMVs from intestinal Escherichia coli could be genotoxic.
OMVs from the avirulent DH5α strain, a pathogenic adherent-invasive E. coli (AIEC) and an enterohaemolytic (EHEC) strain of E. coli were enriched by ultracentrifugation. The effect on the growth and viability of human enterocyte-like Caco-2 cells by OMVs was determined by trypan blue exclusion, MTT and BrdU incorporation assays. The ability of OMVs to induce DNA damage was assayed by single-cell gel electrophoresis, and 8-oxo-dG and γH2Ax immunofluorescence staining. Cytopathological changes were assessed by microscopy. The induction of aneuploidy by the OMVs was measured by flow cytometry in Caco-2 and LoVo cells.
We found that OMVs derived were internalised by Caco-2 cells, increased cell numbers, induced double-stranded DNA breaks, recruited γH2Ax to the nucleus, initiated DNA rereplication, and produced distended multinucleate cells. DH5α and AIEC OMVs caused free radical generation as indicated by the reduction of glutathione in cells, leading to the development of mutagenic 8-oxo-dG adducts in DNA. Flow cytometry revealed that DH5α and EHEC OMVs increased aneuploidy in p53 mutant Caco-2 cells, but not in p53 wild type LoVo cells.
We conclude that E. coli derived OMVs, whether from avirulent or pathogenic strains are potentially genotoxic.
Colorectal cancer is a significant cause of morbidity and mortality. It is the third most common cancer diagnosed amongst men and the second amongst women (663 000 and 571 000 cases each year, respectively)  and is particularly prevalent in Western countries, with the highest incidence in Australasia . The genesis of colorectal cancer is poorly understood, but chromosomal instability is a characteristic of many sporadic colon cancers. The features of chromosomal instability include DNA damage, and failure of DNA repair, leading to aneuploidy .
A number of risk factors have been identified, including, but not restricted to, age, a history of inflammatory bowel disease, a family history of colorectal cancer, obesity, smoking [4, 5] and alcohol use . Recently, it has been proposed that intestinal bacteria, including commensals as well as pathogens, may also play a role in the aetiology of this disease [7–10]. Bacteria were first identified as a cause of cancer when Helicobacter pylori was shown to be involved in the development of gastric cancer . Inevitably, this has led to the hypothesis that other bacteria may also initiate carcinogenesis, particularly those strains that produce toxins [12, 13]. Moreover, there is mounting evidence that bacteria do not need to be invasive to affect this response. Gram-negative bacteria constitutively release outer membrane vesicles (OMVs), both in vivo and in vitro. These 50-200 nm diameter proteoliposomes consist of outer membrane and periplasmic proteins , lipopolysaccharide, peptidoglycans, and may contain DNA and RNA . Many of the constituents of OMVs are the products of virulence genes that include toxins and/or molecules that assist in the attachment to and invasion of target host cells [16–23]. Thus, OMVs may act as long range effectors to remotely deliver toxins to host cells  and provide a further virulence mechanism in addition to, for example, Type IV secretion systems. We recently described that vesicles shed from the surface of a toxin-producing strain of H. pylori are rapidly internalised by human gastric carcinoma AGS cells  alter proliferation and induce oxidative stress, leading to genotoxicity that could result in chromosomal instability .
Escherichia coli are commonly found within the human intestinal tract. Indeed, most E. coli strains are part of the normal microflora of the gut where they contribute to food digestion. In addition, commensal strains of E. coli are thought to compete with potential pathogens (for example by the production of bacteriocins), so inhibiting infection . In contrast, some species of E. coli produce toxins. Whereas these toxins cause diarrheal diseases that can lead to significant illnesses and death , their role as potential carcinogens is less well understood. Given the genotoxicity of H. pylori OMVs, we hypothesised that E. coli OMVs might also induce DNA damage and aneuploidy.
We used the human adenocarcinoma-derived cell line Caco-2 as a model of gut enterocytes and exposed these cells to OMVs constitutively expressed by three strains of E. coli that included an avirulent strain , an adherent-invasive E. coli (AIEC) strain associated with inflammatory bowel disease and colon cancer  and a Shiga toxin (STx)-producing, enterohaemolytic (EHEC) O157:H7 strain associated with bloody diarrheal disease and haemolytic uremic syndrome (HUS) . We examined whether these OMVs were internalised by Caco-2 cells and investigated the effect that the OMVs from each of these three different strains of E. coli had on cell proliferation and viability. The ability of the OMVs to induce abnormal cell morphology, oxidative stress, damage DNA, and produce aneuploid cells was also assessed.
OMVs are internalised by Caco-2 cells
E. coli grown in broth have been shown to constitutively shed OMV . OMVs can be enriched by ultracentrifugation with no biologically active contaminants . We observed that all three strains of E. coli used in this study constitutively shed OMVs and these were numerous in each preparation when examined by TEM. The enriched OMVs ranged in size between 25-200 nm in diameter (arrowed in Figure 1) and these dimensions agree with previously published reports . We have previously shown that in enriched OMVs preparations contaminants, such as flagella, are at least partially depleted [23, 34] and in this study TEM did not reveal significant quantities of these impurities in our OMV preparations from any of the E. coli strains we used. Using immunofluorescence microscopy, we then determined if the OMVs produced by three E. coli strains used in this study are internalised by Caco-2 cells . By labelling OMVs with the fluorescent, membrane-intercalating dye 3,3′-dioctadecyloxacarbocyanine perchlorate (DiO) we were able to show that vesicles entered the cells, irrespective of whether they were from attenuated laboratory or pathogenic strains of E coli. Moreover, orthogonal views reconstructed from image slices 0.28 μm apart, confirmed that the OMVs were located in the perinuclear regions of cells (Figure 2).
OH157:H7 OMVs induce growth of Caco-2 cells, but viability is unaffected
Carcinogenesis is characterised by the dysregulation of cell proliferation, resulting in uncontrolled cell growth , and we hypothesised that E. coli OMVs might increase the growth of Caco-2 cells. In dose response experiments, we determined that doses of OMVs between 0.005 and 5 μg/ml had no significant effect on the growth (Figure 3A) or viability of Caco-2 cells (Figure 3B) over 168 hours. We then monitored the effect that 5 μg/ml OMVs had on cell numbers in kinetic studies by exposing the cells to OMVs for up to 168 hours and conducting trypan blue exclusion assays every second day of culture. We observed that unstimulated control cells continued to grow for the period of the experiment, though the rate of growth began to decline slightly, as expected, as they reached confluence. Cells stimulated with OMVs derived from E. coli strain DH5α also continued to grow throughout the period of the experiment, but there was no significant difference in growth at any time point when the results were normalised to the untreated control cells (Figure 3C). In contrast, exposure to OMVs from the other two strains of E. coli accelerated the Caco-2 cell growth. For LF82 OMVs, these increases were statistically significant after 72 and again at 120 hours, (122% +/- 6, p = 0.021 and 117% +/- 2, p = 0.001, respectively, compared to control) but cell numbers declined thereafter. In the case of O157:H7 OMVs, cells numbers were significantly increased after 72 hours (111% +/- 4, p = 0.036) and remained increased at 168 hours (131% +/- 10, p = 0.039) when compared to untreated control cells (Figure 3C). In contrast, the E. coli OMVs had no significant cytotoxic affect on the Caco-2 cells over time (Figure 3D). Together, these results indicate that DH5α OMVs have no significant effect on cell growth. This is not surprising in the case of DH5α, which is considered to be avirulent and non-pathogenic . Strain LF82 transiently increased cell growth over time and had no effect on cell cytotoxicity, as reported elsewhere . OMVs derived from the more pathogenic O157:H7 strain also had no significant cytotoxic effect on Caco-2 cells. However, these OMVs were associated with a significant increase in cell growth over time, and this growth continued even when unstimulated control cells had reached confluence. These data indicate that LF 82 and O157:H7 OMVs can dysregulate cell growth.
In addition to using trypan blue to determine cell number and viability, we also used the (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)  (Figure 3E) and 5-bromo-2′-deoxyuridine (BrdU) incorporation  (Figure 3F) assays, which are common high-throughput means to determine cell proliferation. Intriguingly, both assays produced results that were contrary to those obtained by use of the trypan blue exclusion assay. In the case of the MTT determinations (which infers viable cell numbers from the reduction of MTT), there was an approximately 20% increase in MTT reduction above that of controls at lower doses, that then decreased with increasing OMV concentration.
The difference between viable cell counts and the results of the BrdU incorporation assays was even more marked, with the incorporation of BrdU in OMV-treated cells measured as up to 400% of control values.
OMVs induce glutathione reduction in Caco-2 cells
The MTT assay is used as a technique to determine cell viability, however it does so by proxy by relying on the reduction of tetrazolium dye to formazan by NAD(P)H-dependent cellular oxidoreductase enzymes. Thus, any agent that affects the expression or activity of these enzymes can affect the assay. For example metabolic uncouplers [39, 40] can falsely give rise to increased cell counts measured by this assay. Furthermore, tetrazolium can be reduced by a variety of agents without increasing cell viability, including genistein , ursolic acid , resveratrol , and interferons . The discrepant data obtained from the MTT assay could also be due to mitochondrial dysfunction, and a consequence of this is the generation of reactive oxygen species (ROS) . Thus, we hypothesised that E. coli OMVs might increase the generation of ROS in Caco-2 cells. There is an inverse correlation between oxidative stress and cellular glutathione (GSH) levels . H. pylori OMVs have been shown to reduce the presence of GSH in AGS cells . Accordingly, we determined the effect of E. coli OMVs on cellular GSH levels (Figure 4A).
The level of GSH in unstimulated Caco-2 cells was 1.4+/-0.7 nM whereas exposure to 200 μM hydrogen peroxide (a positive control to induce oxidative stress) for 24 hours reduced cellular GSH levels to below the limit of detection of the assay. Exposure to OMVs from E. coli strains LF82 or DH5α also had a significant effect on cellular GSH levels, again reducing them to below the limit of detection. In contrast, O157:H7 OMVs added to Caco-2 cells had no significant effect on cellular GSH levels when compared to unstimulated controls (Figure 4A), suggesting that OMVs from some but not all strains of E. coli have the potential to induce oxidative stress in gut epithelial cells.
OMVs generate DNA damage in Caco-2 cells
The generation of ROS can lead to DNA damage [47, 48] and the formation of mutagenic DNA adducts that include 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxo-dG) . Thus, we hypothesised that we would find evidence of 8-oxo-dG adducts within the nuclei of Caco-2 cells exposed to OMVs. Immunofluorescence microscopy was used to demonstrate that OMV exposed cells have increased staining for 8-oxo-dG, indicating a level of oxidative DNA damage not observed in untreated cells. These results suggest that OMVs from a non-pathogenic as well as a pathogenic strain of E. coli (DH5α and LF82, respectively) are capable of inducing mutagenic changes to genomic DNA with the potential to lead later to the initiation of carcinogenesis. In contrast, Caco-2 cells exposed to OMVs from E. coli strain O157:H7 did not display higher levels of 8-oxo-dG labelling (Figure 4B). This would indicate that vesicles from this strain of E. coli do not induce these adducts in Caco-2 cells, a finding that is consistent with the lack of oxidative stress in these cells following exposure O157:H7 OMV.
Free radicals, as well as some bacterial toxins that include the cytolethal distending toxin that is expressed by E. coli O157:H7 and found in their OMVs , can produce double stranded breaks (DSBs) in DNA [50, 51]. Single-cell gel electrophoresis is a powerful technique to quantitate this damage. All three of the OMVs tested induced increases in DSBs with a peak at 0.05 μg/ml OMV for DH5α (13.42% +/- 0.92 DNA in tail, p = 0.001) and LF82 (16.48% +/- 4.29 DNA in tail, p = 0.013) that declined at higher doses compared to control (4.48% +/- 0.77 DNA in tail). In contrast there were significant increases in damage at 0.05 and 5 μg/ml O157:H7 OMVs (16.91% +/- 2.27, p = 0.005 and 17.68 +/- 3.27, p = 0.003 DNA in tail, respectively) (Figure 4C). DNA damage was also evident in Caco-2 cells exposed to 300 μM H2O2 for 24 hours (15.09% +/- 3.56 DNA in tail). Collectively, these results show that OMVs can induce DNA damage in Caco-2 cells. It is possible to speculate that he bell-shaped dose-response curves caused by DH5α and LF82 may indicate that the causes of DNA damage in response to these OMVs may be quite complex, perhaps due the induction of anti-oxidant pathways (e.g. Nrf-2) at higher doses, but this remains to be determined.
E. coli OMVs induce DNA synthesis and repair in Caco-2 cells
DNA damage induces DNA synthesis and repair mechanisms and the large increases in BrdU incorporation described above provide some evidence for this in OMV exposed Caco-2 cells. The BrdU assay measures the incorporation of a thymidine analogue into DNA during the S-phase of the cell cycle . Accordingly, this technique measures the number of actively dividing cells. However, DNA synthesis and hence BrdU incorporation, can be initiated by DNA damage, followed by repair in response to genotoxic agents [52, 53]. Thus, it appears that the large increases in DNA incorporation induced by the E. coli OMVs could be due to DNA damage and repair. There is precedence for this. We have shown that H. pylori OMVs induce DNA damage to AGS gastric carcinoma cells, as determined by cytokinesis-block micronuclei assay .
Another marker of DNA repair is the recruitment and phosphorylation of the histone γH2Ax to the damaged site. This provides a platform for the recruitment of DNA repair enzymes that can be detected by immunofluorescence microscopy [54–56] and we hypothesised that we would detect increased staining for γH2Ax in the nuclei of Caco-2 cells exposed to OMVs. We found that occasional unstimulated cells displayed expression of γH2Ax, as indicated by the punctate green nuclear staining in fluorescence micrographs (Figure 4D). This was expected as cells often constitutively generate free radicals with resultant low level DNA damage . However, following exposure to DH5α and LF82 OMVs, notably more cells displayed the green nuclear staining demonstrating that there was greater recruitment of γH2Ax to DSBs and therefore more DNA damage (Figure 4D) and/or increased initiation of DNA repair. These results were confirmed by quantification by flow cytometry of immunolabelled γH2Ax stimulated and unstimulated Caco-2 cells (Figure 4E). In unstimulated cells, the level of γH2Ax expression was 85.68 +/- 36.07 (mean fluorescence intensity in arbitary units), while DH5α OMV stimulated and LF82 OMV stimulated Caco-2 cells had statistically significant increases in γH2Ax expression (363.82 +/- 35.10, p = 0.029 and 332.54 +/- 109.56, 0.049 respectively, ANOVA followed by Dunnett’s 2-sided post-hoc test). In contrast, O157:H7 OMVs induce no significant increase in γH2Ax expression detected either by immunofluorescence microscopy or flow cytomtery. These data concur with our earlier observations regarding the increases in the incorporation of BrdU and therefore DNA synthesis.
Caco-2 cells exposed to OMVs show significant cytopathological changes consistent with DNA rereplication
When DNA repair fails, some cells escape cell cycle arrest and enter an abnormal mitosis. This process is described as rereplication and is characterised by significant changes in cellular morphology. Affected cells become distended, develop actin stress fibres due to improper cytokinesis, and become micro- and multinucleate . We stained cells exposed to OMVs for 24, 48, and 72 hours for the cytoskeletal proteins cytokeratin-18 and actin while counterstaining with Hoechst 33342, in order to examine cellular and nuclear morphology (Figure 5A). Unstimulated cells remained largely mononucleate with nuclei of a normal size, the cells did not grow in size, and there was no evidence of actin stress fibres over the 3 day period. Also, occasional cells were observed that exhibited micronuclei. In contrast, cells exposed to OMVs displayed many of the features associated with the induction of rereplication. Cells were enlarged, becoming in some cases greater than 300 μm in diameter and additionally showed distended (50 μm diameter) nuclei. Many cells were multinucleate, had multiple micronuclei and developed actin stress fibres. Collectively, these findings suggest that exposure of cells to E. coli. OMVs results in the induction of rereplication.
OMVs induce aneuploidy
After rereplication and cells become tetraploid, p53 mediated signalling induces apoptosis in a process known as mitotic catastrophe, thus deleting DNA damaged cells from the population [59, 60]. This has the purpose of removing potential cancer progenitors from the population. In cells with mutations in the p53 pathway, a failure of mitotic catastrophe to delete DNA damaged cells can lead to chromosomal instability and aneuploidy in subsequent generations of daughter cells, an important mechanism of tumourigenesis [61, 62]. To determine the potential of OMVs to initiate aneuploidy, we stimulated cells with 5 μg/ml OMVs for 168h. The samples were then subjected to DNA content analysis by flow cytometry (Figure 5B). Aneuploid cells can be detected by measurements of cells containing greater than > G2 DNA content. Caco-2 are a chromosomally unstable cell line and aneuploid, so we examined whether there was an increase in the percentage of cells displaying an abnormal DNA content, compared to unstimulated controls. After 168 hours, OMVs derived from O157:H7 bacteria had increased the percentage of cells that contained > G2 compared to unstimulated controls (16.45% +/- 0.76 and 12.45% +/- 0.75, respectively, p = 0.049), as did DH5α OMVs (16.48% +/- 1.01, p = 0.047). LF82 OMVs had no effect on > G2 DNA content after 168 hours (14.87+/- 1.29, p = 0.259). No OMVs had any statistically significant effect on the percentages of cells of sub G0, G0/1, S, or G2 DNA content.
O157:H7 OMV induce G0/1G1 cell cycle arrest and loss of aneuploid cells in chromosomally stable and p53 positive LoVo cells
Caco-2 cells are commonly used in studies of intestinal epithelia as they display many of the characteristics of enterocytes that include the expression of digestive enzymes and apical surface microvilli. However, Caco-2 cells are chromosomally unstable and therefore normally aneuploid. In addition, they also express a non-functional truncated p53. Since p53 is involved in DNA damage signalling and directs cells to either arrest at G0/1 to undergo DNA repair, or undergo apoptosis, we considered that our results from experiments using Caco-2 cells could be influenced by these two factors. We therefore examined whether E. coli OMVs could alter the DNA content and cell cycle of chromosomally stable and p53 wild type LoVo epithelial cells. We found that 4 day exposure to DH5α or LF82-derived OMVs had no effect on the cell cycle or aneuploidy of LoVo cells, but O157:H7 OMVs induced a dose dependent G0/1 cell cycle arrest with a significant reduction in the number of G2/M cells (38.06 +/- 3.25% and 26.41 +/- 3.27% for control and 5μg/ml O157:H7 OMVs respectively, p = 0.035) (Figure 6).
This study was performed to determine if OMVs shed from the surface of an avirulent, a putative pathogenic and an overtly pathogenic strain of E. coli have the potential to induce carcinogenesis in intestinal epithelial cells. By labelling the OMVs with the fluorescent dye DiO, we were able to observe the internalisation of the OMVs into Caco-2 cells. We will perform further experiments to confirm the stability of DiO-labelled OMVs at 4°C. We found that OMVs from all three strains of E. coli examined were internalised into Caco-2 cells, and that two of the three strains were capable of inducing oxidative stress. Intriguingly, the pathogenic strain O157:H7 was the one strain in this study that produced OMVs that did not induce oxidative stress. DNA damage, including mutagenic changes and later aneuploidy, was a consequence of exposing intestinal Caco-2 epithelial cells to E. coli OMVs, irrespective of strain, but OMVs from the strains LF82 and O157:H7 also significantly increased cell proliferation.
Perhaps surprisingly, OMVs from E. coli DH5α, an avirulent strain of E. coli, were capable of inducing free radical formation that was associated with genotoxic changes in cellular DNA, rereplication, and an increase in the percentage of aneuploid cells. However, results of our study are consistent with that of Koturbash et al, who showed that DH5α could induce genotoxicity in murine small intestine, liver, and spleen tissues, even after the bacteria were heat-killed. Collectively, these findings emphasise the need to examine the genotoxic potential of microorganisms currently thought to be non-pathogenic.
Adherent-invasive E. coli strain LF82 is associated with Crohn’s disease , which can lead to colon cancer later in life [64, 65]. Strain LF82 and other AIEC bacteria are considered pathobionts, which are commensal bacteria that can lead to disease. Consistent with a possible role for LF82 in carcinogenesis, we found that OMVs derived from E. coli strain LF82 induced DNA damage, 8-oxo-dG adducts, DNA rereplication, and aneuploidy. As AIEC can colonise the gut and hence can reside in the intestine for considerable periods, the ability of their OMVs to induce ROS and DNA damage suggest that LF82 is, potentially, a significant risk for genotoxic damage within the gut.
It is not known what components of DH5α and LF82 derived OMVs could cause genotoxicity in enterocyte-like cells. We plan to perform a proteomics study to identify potential genotoxins.
Koturbash et al also noted that heat-killed E. coli O157:H7 was genotoxic and our results support this. Strain O157:H7 OMVs did not induce free radical generation, as indicated by GSH assays, nor did they induce the formation of 8-oxo-dG adducts, but they did cause the formation of double strand breaks in Caco-2 cell DNA. OMVs from strain O157:H7 contain cytolethal distending toxin (CDT) . CDT has significant structural and functional homology to eukaryotic Dnase I  and is capable of cutting through DNA strands and therefore generating double strand breaks. This results in significant cell distension, typical of rereplication, and eventually cell death through mitotic catastrophe . However, instead of dying, the O157:H7 OMV-treated cells in our study continued to proliferate, had fewer cells than controls at G0/1 of the cell cycle, and a greater number of aneuploid cells. These data indicate that DNA damaged cells are not depleted from the population, remain aneuploid and could be carcinogenic. We consider that this may relate to the presence of other toxins produced by O157:H7, but this remains to be confirmed. We will conduct further proteomic analyses of O157:H7 OMVs to identify these toxins.
The effects of O157:H7 OMVs appeared to be dependent on the p53 status of the cell line used. In p53 mutant Caco-2 cells, these OMVs increased the numbers of aneuploid cells. In contrast, the number of aneuploid cells was decreased in p53 wild type LoVo cells following exposure to O157:H7 OMVs. There was a small increase in the number of sub-G0/1 cells, compared to unexposed LoVo cells, suggesting the induction of apoptosis (although this requires confirmation). Also, dose dependent G0/1, and to a lesser extent S phase cell cycle arrest was observed. O157:H7 bacteria express Shiga toxins and these are found in their OMVs . Shiga-1 toxin (Stx1) induces p53 mediated cell toxicity . This toxin can also cause S cell cycle arrest in HCT116 cells , a line that is also p53 wild type and chromosomally stable. Our results, which are consistent with these findings, indicate that O157:H7 OMV can induce cell cycle arrest, leading to eventual cell death and removal of aneuploid cells in p53 wild type cells. We will perform additional experiments that involve the knocking in of functional p53 into Caco-2 cells and knocking out of p53 in LoVo cells to further confirm our findings.
Recently, the product of the pks pathogenicity island colibactin has been found to be genotoxic  and prevalent in many pathogenic and commensal B2 E. coli. It is of note that none of the three strains of E. coli examined in this study possess this pathogenicity island [71–73], and therefore the genotoxicity of their OMVs cannot be attributed to colibactin.
Genotoxicity and alterations in cell growth are significant contributors to carcinogenesis. We have shown that each of three E. coli OMVs tested in this study were genotoxic and two were capable of inducing alterations in the rate of cell proliferation in a time-dependent manner. However, these data do not indisputably show that these OMVs are carcinogenic. Further studies, for example in the APC min -/- mouse model , are required to confirm this.
In summary, we have shown that E. coli-derived OMVs are readily internalised into Caco-2 cells, where they are potentially capable of inducing oxidative stress, leading to DNA damage, rereplication and aneuploidy in susceptible cells. In addition, O157:H7 derived OMVs generated aneuploid cells typical of those with chromosomal instability. Thus, we consider E. coli derived OMVs to be genotoxic.
Materials and methods
DMEM, MEM non-essential amino acids, 100× penicillin/streptomycin, foetal bovine serum, Dulbecco’s phosphate-buffered saline (D-PBS), 0.25% w/v trypsin-EDTA, Vybrant™ DiO (3,3′-dioctadecyloxacarbocyanine perchlorate), Hoechst 33342, TRITC-phalloidin, SlowFade antifade reagent, and Alexa 488 and Alexa 594 conjugates were all obtained from Life Technologies (Mulgrave, Victoria, Australia). Vivaspin 500 ultrafiltration were from Sartorius Stedim Biotech GmbH (Goettingen, Germany). Anti-8-oxo-2′-deoxyguanosine (8-oxo-dG) antibody was bought from Trevigen, Inc. (Gaithersburg, MD, United States). Glutathione Assay Kit was purchased from Cayman Biosciences (Sapphire Biosciences, Auckland, New Zealand). Cell Proliferation ELISA, BrdU (colormetric) was obtained from Roche Diagnostics GmbH (Mannheim, Germany). All other reagents were bought from Sigma (Auckland, New Zealand).
Three E. coli strains were used in this study. A non-pathogenic E. coli laboratory strain DH5α , adherent-invasive E. coli (AIEC) strain LF82  and enterohaemolytic E. coli (EHEC) (CDC strain G5244) serotype O157:H7 [New Zealand Reference Culture Collection] . LF82 was kindly provided by Dr. Darfeuille-Michaud (Université d'Auvergne, Clermont-Ferrand, France).
Harvesting and labeling of OMVs
Outer membrane vesicles were harvested as previously described . Briefly, E. coli were grown overnight in Luria Bertani (LB) broth at 37°C with constant rotation (120 rpm). Bacteria were removed by two centrifugations (10 000 × g, 15 minutes, 4°C) and the final supernatants ultracentrifuged (150 000 × g, 3 hours, 4°C) to recover OMVs. The resultant OMV pellet was washed twice times in 0.15 M pH 8.2 Tris-buffered saline (TBS) and filtered through a 0.45 μm syringe filter (to remove any remaining bacteria). Vesicles to be labeled were washed once after recovery then, to standardize labeling, were suspended in 1 ml TBS/50 mg OMV pellet. OMVs were labeled with 1% Vybrant™ DiO by incubation for 20 minutes at 37°C. Free dye was removed by three washes with 300 000 Da cutoff Vivaspin 500 ultrafiltration units. Briefly, OMVs were added to the units with 500 μl of TBS, and then centrifuged at 14 000× g for 25 minutes. The retentate (containing the OMVs) was diluted with 500 μl of TBS and the process repeated twice more. After before being assayed for protein content using a modification of the Lowry assay , unlabeled OMVs were stored at -20°C until required whereas labelled OMVs were stored at 4°C for up to six weeks.
Transmission electron microscopy of OMVs
Transmission electron microscopy (TEM) was used to determine the quality of the OMV preparation. Samples of OMVs were placed on hydrophilic EM grids and stained with 1% v/v phosphotungstic acid, pH 6.8 and viewed with a Philips CM100 transmission electron microscope (Philips/FEI Eindhoven, The Netherlands) operating at 100kV. Images were captured using a MegaView 3 camera (Soft Imaging System GmbH, Münster, Germany).
The Caco-2 and LoVo cells were routinely cultured in Dulbecco’s Modified Eagles Medium with Glutamax I, 4500 mg/l glucose and pyridoxal, supplemented with 10% v/v foetal calf serum, 1% v/v MEM non-essential amino acids, 50 units/ml penicillin and 50 μg/ml streptomycin. The cells were incubated at 37°C, in 5% CO2 and Caco-2 cells passaged 1:10 every 7 days, while LoVo cells were passaged 1:10 every 5 days. Cells (1 × 105 per ml) were routinely plated and cultured for 24 hours (to allow cells to attach) before the addition of OMVs.
Uptake of OMVs by Caco-2 cells
Caco-2 cells plated overnight on ethanol sterilised poly-lysine coated coverslips in 6-well tissue culture plates were then incubated with labelled OMVs (5 μg/ml) for 24 hours. The cells were washed three times with D-PBS, and then fixed in 10% v/v neutral buffered formalin for 15 minutes, before permeabilisation with 0.1% v/v Triton X-100 in D-PBS for 15 minutes. Non-specific binding was blocked with 5% w/v bovine serum albumin in D-PBS for 1hour then stained with TRITC-phalloidin for 1 hour, before counterstaining with 1 μg/ml Hoescht 33342 for 15 minutes. The coverslips were then mounted in ProLong Gold mounting medium. The slides were imaged with a Zeiss Imager Z1 microscope, 40× NA 1.3 objective, Zeiss Apotome structured illumination system and Zeiss MRc camera. Image stacks were taken at 0.28 μm intervals. Images were adjusted for presentation (brightness, contrast and 3-dimensional reconstruction) with NIH ImageJ.
Effect of OMVs on cell viability and proliferation
The ability of the OMVs to affect the long-term viability and proliferation of Caco-2 cells was assessed by Trypan blue exclusion. Caco-2 cells plated into 24-well plates were exposed to 5 μg/ml OMVs for up to 168 hours. At two day intervals, the cells were trypsinised, stained with 0.25% w/v Trypan blue, and counted with a haemocytometer. The Mean Proliferative Index (MPI) at any given point was calculated as:
The dose-dependent effects of OMVs on the proliferation of Caco-2 cells cultured for shorter periods of time were also determined using the MTT and BrdU assays. The MTT assay is based on the mitochondrial reduction of tetrazolium to formazan, a reaction that is considered directly proportional to viable cell numbers. In contrast, the BrdU assay determines incorporation of the thymidine analogue BrdU into DNA during S-phase of the cell cycle to measure proliferation. Caco-2 cells (1 × 104) were plated (in 100 μl of media) into the wells of a 96-well plate and incubated for 24 hours at 37°C before the addition of E. coli OMVs at concentrations between 0.5 ng/ml and 5 μg/ml. After incubation at 37°C for a further 24 hours, 20 μl of 2.5 mg/ml MTT was added to each well and the plate incubated for 5 hours at 37°C. The media was then discarded and 100 μl isopropyl alcohol containing 0.04 M HCl added to each wells. The absorbance of the wells was read at 490 nm with correction at 650 nm. For the BrdU assay, cells were plated and treated as described for the MTT assay and then the degree of BrdU incorporation was determined by Roche Cell Proliferation ELISA, BrdU (Colorimetric), according to manufacturer’s instructions.
Fluorescence microscopy of the cytopathological effects of OMVs
Caco-2 cells (100 000) plated overnight on ethanol sterilised coverslips in tissue culture plates were incubated with labelled OMVs (5 μg/ml) for the times indicated. The cells were fixed with 10% neutral buffered formalin for 15 minutes, and then permeabilised with 0.1% v/v Triton X-100 for 15 minutes. Potential non-specific binding sites were blocked by incubating the coverslips for 1 hour 37°C in 5% w/v bovine serum albumin in D-PBS (blocking buffer). The cells were probed with 1 μg/ml mouse anti-cytokeratin antibody in blocking buffer for 1 hour at 37°C, washed 3 times with D-PBS, then probed again with 1/500 dilution of anti-mouse Alexa 488 conjugate antibody in blocking buffer for 1 hour at 37°C. The cytoskeletal protein actin was stained with TRITC-phalloidin for 1 hour. After washing, the cells were counterstained with 1 μg/ml Hoechst 33342, mounted with SlowFade mounting media and photographed.
Measurement of oxidatative stress by glutathione assay
The potential of OMVs to induce oxidative stress in Caco-2 cells was determined by measurement of glutathione (GSH). Caco-2 cells (100 000) were plated overnight in 24-well tissue culture plates and then exposed to 5 μg/ml of OMVs, or 300 μM H2O2 (positive control) for 24 hours. The cells were lysed by freeze thawing from -80°C three times before assay with Cayman Glutathione Assay Kit, used according to manufacturer’s instructions.
Immunofluorescence microscopy of mutagenic 8-oxo-dG adducts in cells exposed to OMVs
The generation of free radicals in cells can lead to the development of mutagenic 8-oxo-dG adducts in DNA. Immunofluorescence microscopy was used to identify the presence of these lesions in OMV exposed Caco-2 cells. For the detection of 8-oxo-dG in cell nuclei, we followed the primary antibody manufacturer’s instructions. Briefly, the cells were washed 3 times with D-PBS, and then fixed with -30°C 100% v/v ethanol for 20 minutes. After treatment with 0.05N HCl for 5 minutes on ice followed by three washes in D-PBS, the cells were exposed to 100 μg/ml RNAse in 150 mM NaCl, 15 mM sodium citrate for 1 hour at 37°C before being washed sequentially in D-PBS, 35%, 50%, and 75% ethanol for 3 minutes each. DNA was denatured by addition of 0.15 N NaOH in 70% v/v ethanol for 4 minutes, followed by two washes in D-PBS after which the cells were exposed sequentially to 70% ethanol containing 4% v/v formaldehyde, 50% and 35% ethanol, then D-PBS for 2 minutes each. After incubation in 5 μg/ml proteinase K in 20 mM Tris and 1 mM EDTA, pH 7.5 (10 minutes each), the cells were washed 3 times in D-PBS before immunolabeling (as above) with anti-8-oxo-dG antibody and Alexa 488 and counterstaining with Hoechst 33342.
Alkaline single-cell gel electrophoresis (Comet assay) of DNA damage in OMV-exposed Caco-2 cells
DNA damage is a feature of carcinogenesis. We used the alkaline single-cell gel electrophoresis (Comet) assay to determine the degree of double-strand DNA breaks (DSBs) induced by OMVs and hence their genotoxicity. Clear glass slides were coated twice with 1% w/v normal melting point agarose then dried in a 37°C oven. Adherent Caco-2 cells exposed to either OMVs (concentrations between 0.005 and 5 μg/ml) or 300 μM H2O2 (positive control) for 24 hours were trypsinised, washed twice in D-PBS and added to 70 μl 1% low melting point agarose, which was then spread on the coated slides. The agarose-suspended cells were covered with a 22 × 22 mm No1 coverslip and the slides left at 4°C for approximately 30 minutes to allow the agarose the set before the cells were lysed overnight at 4°C in lysis buffer (2.5 M NaCl, 0.1 M EDTA, 10 mM Tris, 1% v/v Triton X-100, pH 10). The slides were transferred to a BioRad horizontal electrophoresis tank containing electrophoresis buffer (0.3 M NaOH, 1 mM EDTA) and left for 40 minutes to equilibrate before being electrophoresed for 25 minutes at 0.5V/cm. After three washes in neutralisation buffer (0.4M Tris pH 7.5) the cells were stained with 0.5 μg/ml Hoechst 33342. The slides were imaged with a Zeiss Imager Z1 with 20× NA 0.5 objective and Zeiss MRc camera. The percentage of DNA in each comet tail (linearly proportional to DNA break frequency) of at least 100 cells per sample was measured with Comet Score IV software (TriTek Corp, VA, USA).
Detection of the DNA damage response histone γH2Ax in cell nuclei
The localisation of phosphorylated histone γH2Ax, which is recruited to sites of DNA damage, was determined in OMV-exposed Caco-2 cells using immunofluorescence microscopy. The cells were treated as described for detection of the cytopathological changes, except mouse-anti-γH2Ax antibody (1 μg/ml) replaced the anti-cytokeratin antibody and the phalloidin staining was omitted.
For quantification of the presence of γH2Ax in the nuclei of OMV exposed cells flow cytometry was used. As γH2Ax can be expressed during the S and G2/M phases of the cell cycle due to DNA replication, only γH2Ax found in G1 was used for quantifiaction as this represents expression due to DNA damage . Caco-2 cells were plated into 24-well tissue culture plates were exposed to 5 μg/ml OMVs for 7 days, then washed in culture medium to remove unbound OMVs. The cells were trypsinised, then fixed in ice-cold ethanol, and stored at -30°C until analysis. The fixed cells were washed three times with D-PBS, the treated with 200 μg/ml RNAse, and stained with 10 μg/ml propidium iodide for at least 30 minutes at room temperature. The cells were then blocked in 5% BSA for 1 hour at 37°C, then incubated in 1 μg/ml anti-gH2Ax antibody for 1 hour at 37C. After washing three times in PBS, 1/500 anti-mouse Alexa 488 was added to the samples for 1 hour at 37°C. The cells were washed then analysed using a Beckman Coulter Cytomics FC500 flow cytometer. γH2Ax positive cells were measured from data gated to the G1 phase of the cells cycle Weasel v3.0 software (Walter and Elizabeth Hall Institute, Melbourne, Australia).
Flow cytometry of Caco-2 and LoVo cell DNA content
A feature of carcinogenesis is the development of chromosomal instability, leading to the generation of cells with abnormally high DNA content (aneuploidy). Flow cytometry was used to assay these changes in OMV exposed cells. As Caco-2 cells are karyotypically unstable, we also used the more stable LoVo cells to investigate the effect of E. coli OMVs on cellular DNA content. Cells (Caco-2 or LoVo, 100 000) were plated into 24-well tissue culture plates were exposed to 5 μg/ml OMVs for 7 days, then washed in culture medium to remove unbound OMVs. The cells were trypsinised, then fixed in ice-cold ethanol, and stored at -30°C until analysis. The fixed cells were washed three times with D-PBS, the treated with 200 μg/ml RNAse, and stained with 10 μg/ml propidium iodide for at least 30 minutes at room temperature. Fluorescence measurements were made using a Beckman Coulter Cytomics FC500 flow cytometer. Cell cycle analysis and the analysis of aneuploidy (cells with greater than G2/M content) was performed with the cell cycle measurement tools of Weasel v3.0 software that deconvolves flow histograms. Gaussian models were fitted to the histogram data to obtain the percentage of cells with sub G1, G0/1, S, G2/M and > G2/M DNA content. Typically, the results were obtained after convergence at 700 iterations.
Data are expressed as mean +/- standard error of the mean (SEM) of three independent experiments. Student’s t-tests and analysis of variance (ANOVA) with Dunnett’s post hoc test was used as tests of statistical significance, as indicated in the Results. P values less than or equal to 0.05 were considered to be significant. Analyses were performed with IBM SPSS versions 17, 19 and 22.
Jemal A, Smith RA, Ward E: Worldwide variations in colorectal cancer. CA Cancer J Clin. 2009, 59: 336-378.
Frizelle FA: Colorectal cancer in New Zealand. N Z Med J. 2007, 120: 1-6.
Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y: Colorectal cancer: genetics of development and metastasis. J Gastroenterol. 2006, 41: 185-192. 10.1007/s00535-006-1801-6.
Buc E, Kwiatkowski F, Alves A, Panis Y, Mantion G, Slim K: Tobacco smoking: a factor of early onset of colorectal cancer. Dis Colon Rectum. 2006, 49: 1893-1896. 10.1007/s10350-006-0704-1.
Kato I, Boleij A, Kortman GA, Roelofs R, Djuric Z, Severson RK, Tjalsma H: Partial associations of dietary iron, smoking and intestinal bacteria with colorectal cancer risk. Nutr Cancer. 2013, 65: 169-177. 10.1080/01635581.2013.748922.
Lightfoot TJ, Barrett JH, Bishop T, Northwood EL, Smith G, Wilkie MJV, Steele RJC, Carey FA, Key TJ, Wolf R, Forman D: Methylene tetrahydrofolate reductase genotype modifies the chemopreventive effect of folate in colorectal adenoma, but not colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2008, 17: 2421-2430. 10.1158/1055-9965.EPI-08-0058.
Collins D, Hogan AM, Winter DC: Microbial and viral pathogens in colorectal cancer. Lancet Oncol. 2011, 12: 504-512. 10.1016/S1470-2045(10)70186-8.
Vogelmann R, Amieva MR: The role of bacterial pathogens in cancer. Curr Opin Microbiol. 2007, 10: 76-81. 10.1016/j.mib.2006.12.004.
Hasan N, Pollack A, Cho I: Infectious causes of colorectal cancer. Infect Dis Clin North Am. 2010, 24: 1019-1039. 10.1016/j.idc.2010.07.009.
Candela M, Guidotti M, Fabbri A, Brigidi P, Franceschi C, Fiorentini C: Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer. Crit Rev Microbiol. 2011, 37 (1): 1-14. 10.3109/1040841X.2010.501760.
Forman D, Newell DG, Fullerton F, Yarnell JWG, Stacey AR, Wald N, Sitas F: Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J. 1991, 302: 1302-1305. 10.1136/bmj.302.6788.1302.
Lax AJ: Bacterial toxins and cancer — a case to answer?. Nat Rev Microbiol. 2005, 3 (April): 3-9.
Lax AJ, Thomas W: How bacteria could cause cancer: one step at a time. Trends Microbiol. 2002, 10: 293-299. 10.1016/S0966-842X(02)02360-0.
Lee E, Bang JY, Park GW, Choi D, Kang JS: Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli. Proteomics. 2007, 7 (17): 3143-3153. 10.1002/pmic.200700196.
Amano A, Takeuchi H, Furuta N: Outer membrane vesicles function as offensive weapons in host-parasite interactions. Microbes Infect. 2010, 12: 791-798. 10.1016/j.micinf.2010.05.008.
Balsalobre C, Silván JM, Berglund S, Mizunoe Y, Uhlin BE, Wai SN: Release of the type I secreted α -haemolysin via outer membrane vesicles from Escherichia coli. Mol Microbiol. 2006, 59: 99-112. 10.1111/j.1365-2958.2005.04938.x.
Bomberger JM, Maceachran DP, Coutermarsh BA, Ye S, George A, Toole O, Stanton BA: Long-distance delivery of bacterial virulence factors by pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog. 2009, 5: e1000382-10.1371/journal.ppat.1000382.
Davis JM, Carvalho HM, Rasmussen SB, O’Brien AD: Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis. Infect Immun. 2006, 74: 4401-4408. 10.1128/IAI.00637-06.
Park K, Choi K, Kim Y, Hong BS, Kim OY, Kim JH, Yoon M, Koh G, Kim Y, Gho YS: Outer membrane vesicles derived from Escherichia coli induce systemic inflammatory response syndrome. PLoS One. 2010, 5: 1-6.
Kesty NC, Mason KM, Reedy M, Miller SE, Kuehn MJ: Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. EMBO J. 2004, 23: 4538-4549. 10.1038/sj.emboj.7600471.
Aldick T, Bielaszewska M, Uhlin BE, Humpf H, Wai SN, Karch H: Vesicular stabilization and activity augmentation of enterohaemorrhagic Escherichia coli haemolysin. Mol Microbiol. 2009, 71: 1496-1508. 10.1111/j.1365-2958.2009.06618.x.
Kouokam JC, Wai SN, Fällman M, Hacker J, Uhlin BE, Fa M, Dobrindt U: Active cytotoxic necrotizing factor 1 associated with outer membrane vesicles from uropathogenic Escherichia coli active cytotoxic necrotizing factor 1 associated with outer membrane vesicles from uropathogenic Escherichia coli. Infect Immun. 2006, 74: 2022-2030. 10.1128/IAI.74.4.2022-2030.2006.
Keenan J, Day T, Neal S, Cook B, Perez-Perez G, Allardyce R, Bagshaw P: A role for the bacterial outer membrane in the pathogenesis of Helicobacter pylori infection. FEMS Microbiol Lett. 2000, 182: 259-264. 10.1111/j.1574-6968.2000.tb08905.x.
Mashburn-Warren LM, Whiteley M: Special delivery: vesicle trafficking in prokaryotes. Mol Microbiol. 2006, 61: 839-846. 10.1111/j.1365-2958.2006.05272.x.
Parker H, Chitcholtan K, Hampton MB, Keenan JI: Uptake of Helicobacter pylori outer membrane vesicles by gastric epithelial cells. Infect Immun. 2010, 78: 5054-5061. 10.1128/IAI.00299-10.
Chitcholtan K, Hampton MB, Keenan JI: Outer membrane vesicles enhance the carcinogenic potential of Helicobacter pylori. Carcinogenesis. 2008, 29: 2400-2405. 10.1093/carcin/bgn218.
Tenaillon O, Skurnik D, Picard B, Denamur E: The population genetics of commensal Escherichia coli. Nat Rev Microbiol. 2010, 8: 207-217. 10.1038/nrmicro2298.
Kaper JB, Nataro JP, Mobley HL: Pathogenic Escherichia coli. Nat Rev Microbiol. 2004, 2: 123-140. 10.1038/nrmicro818.
Chart H, Smith HR, La Ragione RM, Woodward MJ: An investigation into the pathogenic properties of Escherichia coli strains BLR, BL21, DH5a and EQ1. J Appl Microbiol. 2000, 89 (6): 1048-1058. 10.1046/j.1365-2672.2000.01211.x.
Martin HM, Campbell BJ, Hart CAA, Mpofu C, Nayar M, Singh R, Englyst H, Williams HF, Rhodes JM: Enhanced Escherichia coli adherence and invasion in Crohn’s disease and colon cancer. Gastroenterology. 2004, 127: 80-93. 10.1053/j.gastro.2004.03.054.
Karch H, Tarr PI, Bielaszewska M: Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol. 2005, 295: 405-418. 10.1016/j.ijmm.2005.06.009.
Kolling GL, Matthews KR: Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157: H7. Appl Environ Microbiol. 1999, 65: 1843-1848.
Rolhion N, Barnich N, Claret L, Darfeuille-Michaud A: Strong decrease in invasive ability and outer membrane vesicle release in Crohn’s disease-associated adherent-invasive Escherichia coli strain LF82 with the yfgL. J Bacteriol. 2005, 187: 2286-2296. 10.1128/JB.187.7.2286-2296.2005.
Parker H, Keenan JI: Composition and function of Helicobacter pylori outer membrane vesicles. Microbes Infect. 2012, 14: 9-16. 10.1016/j.micinf.2011.08.007.
Mantovani A, Allavena P, Sica A, Balkwill F: Cancer-related inflammation. Nature. 2008, 454: 436-444. 10.1038/nature07205.
Glasser A, Boudeau J, Barnich N, Perruchot M, Colombel J, Darfeuille-michaud A: Adherent invasive Escherichia coli strains from patients with Crohn’ s disease survive and replicate within macrophages without inducing host cell death. Infect Immun. 2001, 69: 5529-5537. 10.1128/IAI.69.9.5529-5537.2001.
Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983, 65: 55-63. 10.1016/0022-1759(83)90303-4.
Martinon F, Rabian C, Loiseau P, Ternynck T, Avrameas SCJ: In vitro proliferation of human lymphocytes measured by an enzyme immunoassay using an anti-5-bromo-2-deoxyuridine monoclonal antibody. J Clin Lab Immunol. 1987, 23: 153-159.
Maioli E, Torricelli C, Fortino V, Carlucci F, Tommassini V, Pacini A: Critical appraisal of the MTT assay in the presence of rottlerin and uncouplers. Biol Proced Online. 2009, 11: 227-240. 10.1007/s12575-009-9020-1.
Collier AC, Pritsos CA: The mitochondrial uncoupler dicumarol disrupts the MTT assay. Biochem Pharmacol. 2003, 66: 281-287. 10.1016/S0006-2952(03)00240-5.
Pagliacci MC, Spinozzi F, Migliorati G, Fumi G, Smacchia M, Grignani F, Riccardi C, Nicoletti I: Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival. Eur J Cancer. 1993, 29A: 1573-1577.
Es-Saady D, Simon A, Jayat-Vignoles C, Chulia AJDC: MCF-7 cell cycle arrested at G1 through ursolic acid, and increased reduction of tetrazolium salts. Anticancer Res. 1996, 16: 481-486.
Bernhard D, Schwaiger W, Crazzolara R, Tinhofer I, Kofler R, Csordas A: Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells. Cancer Lett. 2003, 195: 193-199. 10.1016/S0304-3835(03)00157-5.
Jabbar SAB, Twentyman PR, Watson JV: The MTT assay underestimates the growth inhibitory effects of interferons. Br J Cancer. 1989, 528: 523-528.
Kim GJ, Chandrasekaran K, Morgan WF: Mitochondrial dysfunction, persistently elevated levels of reactive oxygen species and radiation-induced genomic instability: a review. Mutagenesis. 2006, 21: 361-367. 10.1093/mutage/gel048.
Pompella A, Visvikis A, Paolicchi A, Tata V, De Casini AF: The changing faces of glutathione, a cellular protagonist. Biochem Pharmacol. 2003, 66: 1499-1503. 10.1016/S0006-2952(03)00504-5.
Kryston TB, Georgiev AB, Pissis P, Georgakilas AG: Role of oxidative stress and DNA damage in human carcinogenesis. Mutat Res. 2011, 711: 193-201. 10.1016/j.mrfmmm.2010.12.016.
Hua K-F, Liao P-C, Fang Z, Yang F-L, Yang Y-L, Chen Y-L, Chiu Y-C, Liu M-L, Lam Y, Wu S-H: Generation of reactive oxygen species by polyenylpyrroles derivatives causes DNA damage leading to G2/M arrest and apoptosis in human oral squamous cell carcinoma cells. PLoS One. 2013, 8: e67603-10.1371/journal.pone.0067603.
Kasai H: Analysis of a form of oxidative DNA damage, 8-hydroxy-2 X -deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res. 1997, 387: 147-163. 10.1016/S1383-5742(97)00035-5.
Bielaszewska M, Sinha B, Kuczius T, Karch H: Cytolethal distending toxin from Shiga toxin-producing Escherichia coli O157 causes irreversible G 2 / M arrest, inhibition of proliferation, and death of human endothelial cells cytolethal distending toxin from Shiga toxin-producing Escherichia coli O1. Infect Immun. 2005, 73: 552-562. 10.1128/IAI.73.1.552-562.2005.
Elwell CA, Dreyfus LA: DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol Microbiol. 2000, 37: 952-963. 10.1046/j.1365-2958.2000.02070.x.
Zheng Y, Begum S, Zhang C, Fleming K, Masumura C, Zhang M, Smith P, Darlington C: Increased BrdU incorporation reflecting DNA repair, neuronal de-differentiation or possible neurogenesis in the adult cochlear nucleus following bilateral cochlear lesions in the rat. Exp Brain Res. 2011, 210: 477-487. 10.1007/s00221-010-2491-0.
Lee S-H, Hao E, Levine F, Itkin-Ansari P: Id3 upregulates BrdU incorporation associated with a DNA damage response, not replication, in human pancreatic β-cells. Islets. 2011, 3: 358-366. 10.4161/isl.3.6.17923.
Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM: A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol. 2000, 10: 886-895. 10.1016/S0960-9822(00)00610-2.
Pilch DR, Sedelnikova OA, Redon C, Celeste A, Bonner WM: Characteristics of -H2AX foci at DNA double- strand breaks sites. Biochem Cell Biol. 2003, 81: 123-129. 10.1139/o03-042.
Rothkamm K, Kru I, Thompson LH, Lo M: Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol. 2003, 23: 5706-5715. 10.1128/MCB.23.16.5706-5715.2003.
Tanaka T, Halicka HD, Huang X, Traganos F, Darzynkiewicz Z: Constitutive histone H2AX phosphorylation and ATM activation, the reporters of DNA damage by endogenous oxidants. Cell Cycle. 2006, 5: 1940-1945. 10.4161/cc.5.17.3191.
Vitale I, Galluzzi L, Castedo M, Kroemer G: Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol. 2011, 12: 385-392. 10.1038/nrm3115.
Huang H, Fletcher L, Beeharry N, Daniel R, Kao G, Yen TJ, Muschel RJ: Abnormal cytokinesis after X-irradiation in tumor cells that override the G2 DNA damage checkpoint. Cancer Res. 2008, 68: 3724-3732. 10.1158/0008-5472.CAN-08-0479.
Castedo M, Coquelle A, Vivet S, Vitale I, Kauffmann A, Dessen P, Pequignot MO, Casares N, Valent A, Mouhamad S, Schmitt E, Modjtahedi N, Vainchenker W, Zitvogel L, Lazar V, Garrido C, Kroemer G: Apoptosis regulation in tetraploid cancer cells. EMBO J. 2006, 25: 2584-2595. 10.1038/sj.emboj.7601127.
Giaretti W, Venesio T, Prevosto C, Lombardo F, Ceccarelli J, Molinu S, Risio M: Chromosomal instability and APC gene mutations in human sporadic colorectal adenomas. J Pathol. 2004, 204: 193-199. 10.1002/path.1623.
Sadikovic B, Squire JA, Zielenska M: Cause and consequences of genetic and epigenetic alterations in human cancer. Curr Genomics. 2008, 9: 394-408. 10.2174/138920208785699580.
Koturbash I, Thomas JE, Kovalchuk O, Kovalchuk I: Heat-killed bacteria induce genome instability in mouse small intestine, liver and spleen tissues. Cell Cycle. 2009, 8: 1935-1939. 10.4161/cc.8.12.8797.
Bernstein CN, Blanchard JF, Ph D, Kliewer E, Wajda A, Risk C, Bernstein IBD: Cancer risk in patients with inflammatory bowel disease a population-based study. Cancer. 2001, 91: 854-862. 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z.
Itzkowitz SH, Yio X: Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol. 2004, 287: G7-G17. 10.1152/ajpgi.00079.2004.
Friedrich AW, Lu S, Bielaszewska M, Prager R, Bruns P, Xu J, Tschäpe H, Karch H, Tscha H: Cytolethal distending toxin in Escherichia coli O157: H7: spectrum of conservation, structure, and endothelial toxicity. J Clin Microbiol. 2006, 44: 1844-1846. 10.1128/JCM.44.5.1844-1846.2006.
Talukder KA, Azmi IJ, Ahmed KA, Hossain MS, Kabir Y, Cravioto A, Sack DA, Nur-E-Kamal A: Activation of p53/ATM-dependent DNA damage signaling pathway by shiga toxin in mammalian cells. Microb Pathog. 2012, 52: 311-317. 10.1016/j.micpath.2012.02.007.
Bhattacharjee RN, Park K-S, Uematsu S, Okada K, Hoshino K, Takeda K, Takeuchi O, Akira S, Iida T, Honda T: Escherichia coli verotoxin 1 mediates apoptosis in human HCT116 colon cancer cells by inducing overexpression of the GADD family of genes and S phase arrest. FEBS Lett. 2005, 579: 6604-6610. 10.1016/j.febslet.2005.10.053.
Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrède J-P: Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A. 2010, 107: 11537-11542. 10.1073/pnas.1001261107.
Buc E, Dubois D, Sauvanet P, Raisch J, Delmas J, Darfeuille-Michaud A, Pezet D, Bonnet R: High prevalence of mucosa-associated E. Coli producing cyclomodulin and genotoxin in colon cancer. PLoS One. 2013, 8: e56964-10.1371/journal.pone.0056964.
Homburg S, Oswald E, Hacker J, Dobrindt U: Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli. FEMS Microbiol Lett. 2007, 275: 255-262. 10.1111/j.1574-6968.2007.00889.x.
Kresse AU, Rienäcker I, Valle AM, Steinrück H, Claus H, Payne SM, Tschäpe H, Williams PH, Reissbrodt R: Enterohaemorrhagic Escherichia coli O157 and non-O157 serovars differ in their mechanisms for iron supply. Int J Med Microbiol. 2007, 297: 9-15. 10.1016/j.ijmm.2006.11.002.
Miquel S, Peyretaillade E, Claret L, de Vallée A, Dossat C, Vacherie B, Zineb EH, Segurens B, Barbe V, Sauvanet P, Neut C, Colombel J-F, Medigue C, Mojica FJM, Peyret P, Bonnet R, Darfeuille-Michaud A: Complete genome sequence of Crohn’s disease-associated adherent-invasive E. coli strain LF82. PLoS One. 2010, 5 (9): doi: 10.1371/journal.pone.0012714
Thompson MB: The Min mouse: a genetic model for intestinal carcinogenesis. Toxicol Pathol. 1997, 25: 329-332. 10.1177/019262339702500312.
Boudeau J, Glasser A, Masseret E, Joly B, Darfeuille-michaud A: Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn’ s disease invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn’ s disease. Infect Immun. 1999, 67: 4499-4508.
Markwell MAK, Haas SM, Tolbert NE: Determination of the Lowry procedure to simplify protein in membrane and lipoprotein. Anal Biochem. 1978, 210: 206-210.
MacPhail S, Banath J, Yu Y, Chu E, Olive P: Cell-cycle dependent expression of phosphorylated histone H2Ax reduced expression in unirradiated but not X-irradiated G1-phase cells. Radiat Res. 2003, 159: 759-767. 10.1667/RR3003.
We would like to thank Dr Richard Easingwood of Microscopy Otago, University of Otago, Dunedin, New Zealand for providing the electron microscopy images. This work was supported by a grant from Lottery Health Research.
We declare that we have no competing interests.
PT cultured the cells, performed and designed the experiments, and conducted the statistical analyses. In addition he wrote the manuscript. FF contributed to the experimental design and manuscript. JK grew bacteria and prepared the OMVs, designed the experiments and contributed to the manuscript. All authors read and approved the final manuscript.
Authors’ original submitted files for images
About this article
Cite this article
Tyrer, P.C., Frizelle, F.A. & Keenan, J.I. Escherichia coli-derived outer membrane vesicles are genotoxic to human enterocyte-like cells. Infect Agents Cancer 9, 2 (2014). https://doi.org/10.1186/1750-9378-9-2
- Escherichia coli
- Outer membrane vesicles
- Colorectal cancer